Literature DB >> 7902856

Characterization of a high molecular weight tumor necrosis factor-alpha mRNA in influenza A virus-infected macrophages.

H Sprenger1, M Bacher, E Rischkowsky, A Bender, M Nain, D Gemsa.   

Abstract

Infection by influenza A virus has previously been shown to prime macrophages for a high TNF-alpha production. Influenza A virus induced a TNF-alpha mRNA accumulation that consisted of two types: a regular 1.7 kb and an additional high m.w. 2.4 kb species in murine macrophages, and a high m.w. 3.6 kb species in human monocytes. In this study, we further characterized this virus-induced, novel high m.w. TNF-alpha mRNA. The additional high m.w. TNF-alpha mRNA represented a true polyadenylated mRNA and its induction required exposure to infectious viruses. The regular and the high m.w. TNF-alpha mRNA were both found in the nuclear fraction and the cytoplasm. We excluded that the novel high m.w. TNF-alpha mRNA was an intron-containing precursor TNF-alpha mRNA that could have persisted in virus-infected macrophages. When TNF-alpha exons 1 to 4 and TNF-alpha exons 2 to 4 were amplified by polymerase chain reaction, only regular and no high m.w. bands were detected. By use of specific TNF-alpha intron I and intron III cDNA we could definitely demonstrate the absence of introns in the high m.w. TNF-alpha mRNA. The high m.w. TNF-alpha mRNA was free of TNF-beta and TNF intergenic region elements but contained the 5' and 3' untranslated region of TNF-alpha. Influenza A virus infection also induced a double band of IL-1 beta and IL-6 mRNA. Whether this novel high m.w. TNF-alpha mRNA represents a virus-induced abnormality or a superinduction of an otherwise normal but minor TNF-alpha transcript, and whether this high m.w. TNF-alpha mRNA species codes for a biologically active product, remains to be examined.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7902856

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Expression of influenza virus hemagglutinin activates transcription factor NF-kappa B.

Authors:  H L Pahl; P A Baeuerle
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

Review 2.  The prospect for cytokine based therapeutic strategies in rheumatoid arthritis.

Authors:  G V Campion
Journal:  Ann Rheum Dis       Date:  1994-08       Impact factor: 19.103

3.  Local expression of tumor necrosis factor alpha in an experimental model of acute osteomyelitis in rats.

Authors:  A J Littlewood-Evans; M R Hattenberger; C Lüscher; A Pataki; O Zak; T O'Reilly
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

4.  Borrelia burgdorferi induces chemokines in human monocytes.

Authors:  H Sprenger; A Krause; A Kaufmann; S Priem; D Fabian; G R Burmester; D Gemsa; M G Rittig
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

5.  Inhibition of influenza virus replication by nitric oxide.

Authors:  G F Rimmelzwaan; M M Baars; P de Lijster; R A Fouchier; A D Osterhaus
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

6.  Induction of programmed cell death by parvovirus H-1 in U937 cells: connection with the tumor necrosis factor alpha signalling pathway.

Authors:  B Rayet; J A Lopez-Guerrero; J Rommelaere; C Dinsart
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

7.  Selective induction of monocyte and not neutrophil-attracting chemokines after influenza A virus infection.

Authors:  H Sprenger; R G Meyer; A Kaufmann; D Bussfeld; E Rischkowsky; D Gemsa
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.